Adiposogenital dystrophy cost-effectiveness of therapy
|
Adiposogenital dystrophy Microchapters |
|
Differentiating Adiposogenital dystrophy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Adiposogenital dystrophy cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Adiposogenital dystrophy cost-effectiveness of therapy |
|
FDA on Adiposogenital dystrophy cost-effectiveness of therapy |
|
CDC on Adiposogenital dystrophy cost-effectiveness of therapy |
|
Adiposogenital dystrophy cost-effectiveness of therapy in the news |
|
Blogs on Adiposogenital dystrophy cost-effectiveness of therapy |
|
Risk calculators and risk factors for Adiposogenital dystrophy cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ogechukwu Hannah Nnabude, MD
Overview
Treatment of adiposogenital dystrophy can very expensive, with hormone replacement and surgery costing tens of thousands of dollars per year.
Cost-effectiveness of therapy
The cost of treatment of adiposogenital dystrophy can be a financial strain. Hormone replacement can cost tens of thousands per year. For example, the cost of growth hormone replacement can be $20000 or more per year[1]. Surgical treatment is also in the tens of thousands of dollars. Average cost of a full surgical day for intracranial tumor resection in the pediatric population was $15905 in 2014. This excluded cost for in-patient stay and other expenses[2].
References
- ↑ Lee JM, Davis MM, Clark SJ, Hofer TP, Kemper AR (2006). "Estimated cost-effectiveness of growth hormone therapy for idiopathic short stature". Arch Pediatr Adolesc Med. 160 (3): 263–9. doi:10.1001/archpedi.160.3.263. PMID 16520445.
- ↑ Stapleton AL, Tyler-Kabara EC, Gardner PA, Snyderman CH (2015). "The costs of skull base surgery in the pediatric population". J Neurol Surg B Skull Base. 76 (1): 39–42. doi:10.1055/s-0034-1390019. PMC 4318741. PMID 25685648.